CooleyยทPHARMA / BIOTECH
Treasury's Proposed COINS Rule Could Reshape China-to-West Biotech NewCo Terms
Cooley reports a proposed US Treasury rule could limit Chinese licensor equity in NewCo vehicles, altering equity-vs-contractual-return terms in China-to-West biotech transactions.
treasury-coins-ruleoutbound-investmentchina-biotech-licensingnewco-structurescross-border-deal-terms
Read the original firm alert โ Wednesday, November 4, 2026